Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998 - PubMed (original) (raw)
. 2002 Jul 23;59(2):280-2.
doi: 10.1212/wnl.59.2.280.
Affiliations
- PMID: 12136072
- DOI: 10.1212/wnl.59.2.280
Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998
Eric J Sorenson et al. Neurology. 2002.
Abstract
The authors sought to determine trends in the incidence of ALS in Olmsted County from 1925 to 1998. Seventy-seven cases of ALS were identified during the period studied. The incidence rate remained stable at 1.7 cases per 100,000 people per year. Mean age at onset was 63 years. Mean survival was 23 months from diagnosis. Mean survival for patients <60 years old was 31 months; for patients aged >or=60 years, it was 20 months (p = 0.02). Mean time from symptom onset to diagnosis was 13 months. Neither survival nor time to diagnosis changed significantly over time.
Comment in
- Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998.
Chiò A, Mora G, Mutani R, Schiffer D. Chiò A, et al. Neurology. 2003 May 13;60(9):1560; author reply 1560-1. Neurology. 2003. PMID: 12743264 No abstract available. - Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998.
Testa D, Filippini G. Testa D, et al. Neurology. 2003 May 13;60(9):1560; author reply 1560-1. Neurology. 2003. PMID: 14682318 No abstract available.
Similar articles
- Incidence of aspiration pneumonia in ALS in Olmsted County, MN.
Sorenson EJ, Crum B, Stevens JC. Sorenson EJ, et al. Amyotroph Lateral Scler. 2007 Apr;8(2):87-9. doi: 10.1080/17482960601147461. Amyotroph Lateral Scler. 2007. PMID: 17453635 - Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998.
Chiò A, Mora G, Mutani R, Schiffer D. Chiò A, et al. Neurology. 2003 May 13;60(9):1560; author reply 1560-1. Neurology. 2003. PMID: 12743264 No abstract available. - Epidemiology of amyotrophic lateral sclerosis in Minnesota: a year-long population based study.
Harper CJ, Sorenson EJ, Mandrekar J. Harper CJ, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(7-8):520-3. doi: 10.3109/21678421.2015.1051991. Epub 2015 Jun 17. Amyotroph Lateral Scler Frontotemporal Degener. 2015. PMID: 26083871 - Patients who survive 5 years or more with ALS in Olmsted County, 1925-2004.
Mateen FJ, Carone M, Sorenson EJ. Mateen FJ, et al. J Neurol Neurosurg Psychiatry. 2010 Oct;81(10):1144-6. doi: 10.1136/jnnp.2009.201251. Epub 2010 Jul 13. J Neurol Neurosurg Psychiatry. 2010. PMID: 20627966 Free PMC article. - The epidemiology of amyotrophic lateral sclerosis.
Talbott EO, Malek AM, Lacomis D. Talbott EO, et al. Handb Clin Neurol. 2016;138:225-38. doi: 10.1016/B978-0-12-802973-2.00013-6. Handb Clin Neurol. 2016. PMID: 27637961 Review.
Cited by
- Temporal trend of amyotrophic lateral sclerosis incidence in southern Europe: a population study in the health district of Ferrara, Italy.
Govoni V, Cesnik E, Casetta I, Tugnoli V, Tola MR, Granieri E. Govoni V, et al. J Neurol. 2012 Aug;259(8):1623-31. doi: 10.1007/s00415-011-6390-5. Epub 2012 Jan 10. J Neurol. 2012. PMID: 22231873 - Secular Trends of Amyotrophic Lateral Sclerosis: The Piemonte and Valle d'Aosta Register.
Chiò A, Mora G, Moglia C, Manera U, Canosa A, Cammarosano S, Ilardi A, Bertuzzo D, Bersano E, Cugnasco P, Grassano M, Pisano F, Mazzini L, Calvo A; Piemonte and Valle d’Aosta Register for ALS (PARALS). Chiò A, et al. JAMA Neurol. 2017 Sep 1;74(9):1097-1104. doi: 10.1001/jamaneurol.2017.1387. JAMA Neurol. 2017. PMID: 28692730 Free PMC article. - Defining SOD1 ALS natural history to guide therapeutic clinical trial design.
Bali T, Self W, Liu J, Siddique T, Wang LH, Bird TD, Ratti E, Atassi N, Boylan KB, Glass JD, Maragakis NJ, Caress JB, McCluskey LF, Appel SH, Wymer JP, Gibson S, Zinman L, Mozaffar T, Callaghan B, McVey AL, Jockel-Balsarotti J, Allred P, Fisher ER, Lopate G, Pestronk A, Cudkowicz ME, Miller TM. Bali T, et al. J Neurol Neurosurg Psychiatry. 2017 Feb;88(2):99-105. doi: 10.1136/jnnp-2016-313521. Epub 2016 Jun 3. J Neurol Neurosurg Psychiatry. 2017. PMID: 27261500 Free PMC article. - ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): study methodology, recruitment, and baseline demographic and disease characteristics.
Mitsumoto H, Factor-Litvak P, Andrews H, Goetz RR, Andrews L, Rabkin JG, McElhiney M, Nieves J, Santella RM, Murphy J, Hupf J, Singleton J, Merle D, Kilty M, Heitzman D, Bedlack RS, Miller RG, Katz JS, Forshew D, Barohn RJ, Sorenson EJ, Oskarsson B, Fernandes Filho JA, Kasarskis EJ, Lomen-Hoerth C, Mozaffar T, Rollins YD, Nations SP, Swenson AJ, Shefner JM, Andrews JA, Koczon-Jaremko BA; ALS COSMOS Study Group. Mitsumoto H, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2014 Jun;15(3-4):192-203. doi: 10.3109/21678421.2013.864312. Epub 2014 Feb 24. Amyotroph Lateral Scler Frontotemporal Degener. 2014. PMID: 24564738 Free PMC article. - State and metropolitan area-based amyotrophic lateral sclerosis (ALS) surveillance.
Wagner L, Rechtman L, Jordan H, Ritsick M, Sanchez M, Sorenson E, Kaye W. Wagner L, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2015;17(1-2):128-34. doi: 10.3109/21678421.2015.1074699. Epub 2015 Sep 23. Amyotroph Lateral Scler Frontotemporal Degener. 2015. PMID: 26399278 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous